Vaccination in pregnancy

Women's Health

Volumn 7, Issue 1, 2011, Pages 109-119

  Al Safi, Zain A ^a   Shavell, Valerie I ^a   Gonik, Bernard ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

immunization; postpartum; pregnancy; vaccination; vaccine

Indexed keywords

CHICKENPOX VACCINE; CYTOMEGALOVIRUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; PLACEBO; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RUBELLA VACCINE; STREPTOCOCCUS VACCINE; TYPHOID VACCINE;

ABSENCE OF SIDE EFFECTS; ACTIVE IMMUNIZATION; BREAST FEEDING; CHICKENPOX; CLINICAL TRIAL; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DIPHTHERIA; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FETUS OUTCOME; FLU LIKE SYNDROME; GROUP B STREPTOCOCCAL INFECTION; HEPATITIS A; HEPATITIS B; HIGH RISK PREGNANCY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; MEASLES; MEASLES VACCINATION; MEDICOLEGAL ASPECT; MUMPS; NEWBORN INFECTION; NEWBORN TETANUS; PASSIVE IMMUNIZATION; PERTUSSIS; PLACENTAL TRANSFER; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PRIMARY PREVENTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RUBELLA; SEASONAL INFLUENZA; SINGLE DRUG DOSE; TERATOGENICITY; TETANUS PROPHYLAXIS; TYPHOID FEVER; VACCINATION; VACCINE PRODUCTION; VERTICAL TRANSMISSION;

FEMALE; GUIDELINES AS TOPIC; HUMANS; IMMUNIZATION, PASSIVE; LACTATION; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; VACCINES;

EID: 78650665935     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.10.86     Document Type: Review

References (59)

1. Centers for Disease Control and Prevention: Summary of notifiable diseases - United States 2008. MMWR Morb. Mortal. Wkly. Rep. 57(54), 1-94 (2010).
2. Englund JA: The influence of maternal immunization on infant immune responses. J. Comp. Pathol. 137(Suppl. 1), S16-S19 (2007).
3. Munoz FM, Englund JA: A step ahead. Infant protection through maternal immunization. Pediatr. Clin. North Am. 47(2), 449-463 (2000).
4. Munoz FM, Englund JA, Vaccines in pregnancy. Infect Dis. Clin. North Am. 15(1), 253-271 (2001).
5. Heinonen OP, Slone D, ShapiroS: Immunizing agents. In: Birth Defects and Drugs in Pregnancy. Kaufman DW (Ed.). Publishing Sceinces Group, Littleton, MA, USA, 314-321 (1997).
6. Gonik B, Fasano N, Foster S: The obstetrician-gynecologists role in adult immunization. Am. J. Obstet. Gynecol. 187(4), 984-988 (2002).
7. Ingardia CJ, Kelley L, Steinfeld JD, Wax JR: Hepatitis B vaccination in pregnancy: factors influencing efficacy. Obstet. Gynecol. 93(6), 983-986 (1999).
8. Henderson DC: Mercury in vaccines-reassuring news. Lancet 360(9347), 1711-1712 (2002).
9. Thompson WW, Price C, Goodson B et al.: Early thimerosal exposure and neuropsychological outcomes at 7 to 10 in situ. N. Engl. J. Med. 357(13), 1281-1292 (2007).
10. Verstraeten T, Davis RL, DeStefano F et al.: Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 112(5), 1039-1048 (2003).
11. Pichichero ME, Gentile A, Giglio N et al.: Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines. J. Pediatr. 155(4), 495-499 (2009).
12. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Services (USPHS). Pediatrics 104, 568-569 (1999).
13. Fiore AE, Shay DK, Broder K et al.: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep. 58(RR8), 1-52 (2009).
14. Losonsky GA, Fishaut JM, Strussenberg J, Ogra PL: Effect of immunization against rubella on lactation products. II. Maternal-neonatal interactions. J. Infect. Dis. 145(5), 661-666 (1982).
15. Bohlke K, Galil K, Jackson LA et al.: Postpartum varicella vaccination: is the vaccine virus excreted in breast milk? Obstet. Gynecol. 102(5 Pt 1), 970-977 (2003).
16. Centers for Disease Control and Prevention: General recommendations on immunization. MMWR Morb. Mortal. Wkly. Rep. 55(RR15), 1-48 (2006).
17. HackleyB: Incorporating immunization services into reproductive health care. J. Midwifery Womens Health 53(3), 175-187, quiz 284-285 (2008).
18. Center for Disease Control and Prevention: Prevention of hepatitis A through active of passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 55(RR7), 1-23 (2006
19. Elinav E, Ben-Dov IZ, Shapira Y et al.: Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 130(4), 1129-1134 (2006).
20. Urganci N, Arapoglu M, Akyildiz B, Nuhoǧlu A: Neonatal cholestasis resulting from vertical transmission of hepatitis A infection. Pediatr. Infect. Dis. J. 22(4), 381-382 (2003).
21. American College of Obstetricians and Gynecologists: Viral hepatitis in pregnancy. Obstet. Gynecol. 110, 941-955 (2007).
22. Center for Disease Control and Prevention, Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal Wkly Rep. 56(41), 1080-1084 (2007).
23. Center for Disease Control and Prevention: A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 54 (RR16), 1-31 (2005).
24. Levy M, Koren G: Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am. J. Perinatol. 8(3), 227-232 (1991).
25. Carroll ID, Williams DC: Pre-travel vaccination and medical prophylaxis in the pregnant traveler. Travel Med. Infect. Dis. 6(5), 259-275 (2008).
26. Carlson A, Thung SF, Norwitz ER: H1N1 Influenza in pregnancy: what all obstetric care providers ought to know. Rev. Obstet. Gynecol. 2(3), 139-145 (2009).
27. Mak TK, Mangtani P, Leese J et al.: Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect. Dis. 8(1), 44-52 (2008).
28. MacDonald NE, Riley LE, Steinhoff MC: Influenza immunization in pregnancy. Obstet. Gynecol. 114(2 Pt 1), 365-368 (2009).
29. Zaman K, Roy E, Arifeen SE et al.: Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med. 359(15), 1555-1564 (2008).
30. Tamma PD, Ault KA, del Rio C et al.: Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol. 201(6), 547-552 (2009).
31. ACOG Committee on Obstetric Practice: Influenza vaccination and treatment during pregnancy. ACOG Committee Opinion No. 305. Obstet. Gynecol. 104(5 Pt 1), 1125-1126 (2004).
32. Mouzoon ME, Munoz FM, Greisinger AJ et al.: Improving influenza immunization in pregnant women and healthcare workers. Am. J. Manag. Care 16(3), 209-216 (2010).
33. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA: 2009 H1N1 influenza. Mayo. Clin. Proc. 85(1), 64-76 (2010).
34. Louie JK, Acosta M, Jamieson DJ et al.: Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N. Engl. J. Med. 362(1), 27-35 (2010).
35. Jamieson DJ, Honein MA, Rasmussen SA et al.: H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374(9688), 451-458 (2009).
36. Center for Disease Control and Prevention: Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 58(RR10), 1-8 (2009).
37. Centers for Disease Control and Prevention: Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 46(RR8), 1-24 (1997).
38. Munoz FM, Englund JA, Cheesman CC et al.: Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 20(5-6), 826-837 (2001).
39. Shahid NS, Steinhoff MC, Hoque SS, Begum T, Thompson C, Siber GR: Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 346(8985), 1252-1257 (1995).
40. Centers for Disease Control and Prevention: Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 49(RR5), 1-22; quiz CE1-7 (2000).
41. Centers for Disease Control and Prevention: Progress toward interruption of wild poliovirus transmission - worldwide, January 2007-April 2008. MMWR Morb. Mortal. Wkly Rep. 57(18), 489-494 (2008).
42. Harjulehto-Mervaala T, Hovi T, Aro T, Saxén H, Hiilesmaa VK: Oral poliovirus vaccination and pregnancy complications. Acta. Obstet. Gynecol. Scand. 74(4), 262-265 (1995).
43. Centers for Disease Control and Prevention: Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 47(RR8), 1-57(1998).
44. Gruslin A, Steben M, Halperin S et al., Immunization in pregnancy. J. Obstet. Gynaecol. Can. 31(11), 1085-1101 (2009).
45. Centers for Disease Control and Prevention: Prevention of pertussis, tetanus and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 57(RR4), 1-51 (2008).
46. Wendelboe AM, Njamkepo E, Bourillon A et al.: Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 26(4), 293-299 (2007).
47. Centers for Disease Control and Prevention: Typhoid immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 43(RR14), 1-7(1994).
48. Centers for Disease Control and Prevention: Prevention of varicella recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 56(RR4), 1-48 (2007).
49. Pass RF, Zhang C, Evans A et al.: Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360(12), 1191-1199 (2009).
50. Sharma S, Pathak S: Malaria vaccine, a current perspective. J. Vector Borne Dis. 45(1), 1-20 (2008).
51. Tuikue Ndam N, Deloron P: Towards a vaccine against pregnancy-associated malaria. Parasite 15(3), 515-521 (2008).
52. Edwards MS: Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum. Vaccin. 4(6), 444-448 (2008).
53. Munoz FM, Piedra PA, Glezen WP: Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 21(24), 3465-3467 (2003).
54. Brent RL: Risks and benefits of immunizing pregnant women: the risk of doing nothing. Reprod. Toxicol. 21(4), 383-389 (2006).
55. Chang S, Ball R, Braun MM: Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006. Vaccine 26(19), 2428-2432 (2008).
56. Trannoy E: Will ethical and liability issues and public acceptance allow maternal immunization? Vaccine 16(14-15), 1482-1485 (1998).
57. Glezen WP: Session IV. Ethical, liability and regulatory issues. Vaccine 21(24), 3501-3502 (2003).
58. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group: Historical comparisons of morbidity and mortality for vaccine preventable diseases in the United States. JAMA 298(18), 2155-2163 (2007).
59. Centers for Disease Control and Prevention: Receipt of influenza vaccine during pregnancy among women with live births - Georgia and Rhode Island, 2004-2007. MMWR 58(35), 972-975 (2009).